SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001318641-18-000023
Filing Date
2018-05-15
Accepted
2018-05-15 08:16:53
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbli-033118x10q.htm 10-Q 570489
2 EXHIBIT 31.1 cbli-033118xex311.htm EX-31.1 13323
3 EXHIBIT 32.1 cbli-033118xex321.htm EX-32.1 8076
  Complete submission text file 0001318641-18-000023.txt   3476880

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20180331.xml EX-101.INS 593809
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbli-20180331.xsd EX-101.SCH 30504
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbli-20180331_cal.xml EX-101.CAL 46857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbli-20180331_def.xml EX-101.DEF 160555
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbli-20180331_lab.xml EX-101.LAB 461147
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbli-20180331_pre.xml EX-101.PRE 266436
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 18833184
SIC: 8731 Services-Commercial Physical & Biological Research